BF Biosciences gains DRAP's approval for brownfield expansion

By MG News | Category Equity | September 09, 2024 at 11:49 AM GMT+05:00

0:00

September 09, 2024 (MLN): BF Biosciences Limited, a subsidiary of Ferozsons Laboratories Limited (PSX: FEROZ), has secured approval from the Drug Regulatory Authority of Pakistan (DRAP) for its brownfield expansion (Line II).

This expansion includes a pre-filled syringes line, a liquid and lyophilized line, and a product development section.

The commercial production from the pre-filled syringes line has commenced, whereas the liquid & lyophilized line is under internal validation and will start commercial production in the second quarter of FY 2024-25.

Additionally, BF Biosciences Limited has launched Sematide (Semaglutide) in a pre-filled syringe.

Sematide is the first Glucagon-Like Peptide 1 (GLP1) receptor agonist approved for local manufacture in Pakistan, offering a convenient solution for diabetes management.

The pre-filled syringe eliminates dosing errors and is easy to use by the patients.

Sematide is being manufactured at the new state-of-the-art European prefilled syringes line of BF Biosciences Limited.

Copyright Mettis Link News

Related News

Name	Price/Vol	%Chg/NChg
KSE100	121,641.00 407.56M	-0.13% -157.87
ALLSHR	75,951.71 854.04M	-0.10% -76.82
KSE30	36,827.89 67.82M	-0.42% -156.03
KMI30	181,199.42 117.76M	-0.38% -696.40
KMIALLSHR	52,088.08 592.55M	-0.27% -143.41
BKTi	29,808.04 22.21M	-0.83% -249.97
OGTi	27,075.99 4.68M	-0.75% -203.95

Symbol	Bid/Ask	High/Low

Name	Last	High/Low	Chg/%Chg
BITCOIN FUTURES	105,060.00	105,945.00 101,390.00	2845.00 2.78%
BRENT CRUDE	66.65	66.67 64.80	1.31 2.00%
RICHARDS BAY COAL MONTHLY	90.00	90.75 90.00	0.00 0.00%
ROTTERDAM COAL MONTHLY	101.80	102.40 101.00	1.25 1.24%
USD RBD PALM OLEIN	998.50	998.50 998.50	0.00 0.00%
CRUDE OIL - WTI	64.77	64.80 62.82	1.40 2.21%
SUGAR #11 WORLD	16.51	16.59 16.32	-0.06 -0.36%